STERIS Historical Income Statement

STE Stock

USD 217.47 1.41 0.65%

Historical analysis of STERIS Plc income statement accounts such as Operating Income of 877.9 M, Ebit of 889.5 M, EBITDA of 1.5 B or Cost Of Revenue of 3.1 B can show how well STERIS plc performed in making a profits. Evaluating STERIS Plc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of STERIS Plc's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining STERIS plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether STERIS plc is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.

About STERIS Income Statement Analysis

STERIS plc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to STERIS Plc shareholders. The income statement also shows STERIS investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

STERIS Plc Income Statement Chart

At present, STERIS Plc's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 2.3 B, whereas Selling And Marketing Expenses is forecasted to decline to about 14 M.

Total Revenue Gross Profit Other Operating Expenses Operating Income Ebitda Net Interest Income

Total Revenue

Total revenue comprises all receipts STERIS plc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of STERIS plc minus its cost of goods sold. It is profit before STERIS Plc operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of STERIS plc. It is also known as STERIS Plc overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from STERIS plc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of STERIS plc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Most accounts from STERIS Plc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into STERIS plc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.At present, STERIS Plc's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 2.3 B, whereas Selling And Marketing Expenses is forecasted to decline to about 14 M.

	2021	2022	2023	2024 (projected)
Total Revenue	4.6B	5.0B	5.1B	5.4B
Depreciation And Amortization	553.1M	552.9M	565.2M	593.5M

Total Revenue Depreciation And Amortization

STERIS Plc income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Total Other Income Expense Net	Interest Expense	Income Before Tax	Net Income	Income Tax Expense	Research Development	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Minority Interest	Tax Provision	Non Recurring	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items	Non Operating Income Net Other
Depreciation And Amortization		0.97	0.97	0.97	0.77	0.89	0.96	0.97	0.97	-0.84	0.96	0.61	0.49	0.59	0.94	0.98	0.84	0.44	-0.4	0.3	0.96	-0.12	-0.9	0.93	-0.62	-0.87
Total Revenue	0.97		1.0	1.0	0.81	0.9	0.96	1.0	0.98	-0.85	0.95	0.71	0.61	0.7	0.99	0.95	0.81	0.52	-0.3	0.36	0.88	-0.13	-0.83	0.84	-0.6	-0.77
Gross Profit	0.97	1.0		1.0	0.81	0.91	0.96	1.0	0.98	-0.84	0.94	0.71	0.62	0.69	0.98	0.96	0.81	0.53	-0.32	0.36	0.88	-0.13	-0.83	0.85	-0.6	-0.78
Other Operating Expenses	0.97	1.0	1.0		0.79	0.88	0.94	1.0	0.99	-0.85	0.94	0.68	0.58	0.67	0.99	0.96	0.81	0.48	-0.29	0.32	0.88	-0.13	-0.82	0.85	-0.58	-0.79
Operating Income	0.77	0.81	0.81	0.79		0.79	0.81	0.81	0.74	-0.74	0.87	0.91	0.76	0.87	0.81	0.69	0.61	0.69	-0.35	0.61	0.74	-0.46	-0.77	0.6	-0.85	-0.61
Ebit	0.89	0.9	0.91	0.88	0.79		0.98	0.9	0.83	-0.77	0.9	0.75	0.62	0.74	0.89	0.81	0.73	0.57	-0.54	0.52	0.84	-0.11	-0.85	0.79	-0.69	-0.68
Ebitda	0.96	0.96	0.96	0.94	0.81	0.98		0.95	0.92	-0.82	0.95	0.71	0.58	0.7	0.94	0.91	0.79	0.53	-0.5	0.44	0.91	-0.12	-0.89	0.87	-0.68	-0.78
Cost Of Revenue	0.97	1.0	1.0	1.0	0.81	0.9	0.95		0.98	-0.87	0.95	0.7	0.61	0.7	0.99	0.94	0.81	0.51	-0.28	0.35	0.87	-0.12	-0.82	0.83	-0.6	-0.77
Total Operating Expenses	0.97	0.98	0.98	0.99	0.74	0.83	0.92	0.98		-0.8	0.91	0.61	0.53	0.6	0.96	0.99	0.8	0.43	-0.29	0.27	0.89	-0.14	-0.8	0.88	-0.52	-0.81
Total Other Income Expense Net	-0.84	-0.85	-0.84	-0.85	-0.74	-0.77	-0.82	-0.87	-0.8		-0.9	-0.57	-0.4	-0.58	-0.85	-0.78	-0.83	-0.39	0.15	-0.3	-0.79	-0.01	0.8	-0.7	0.63	0.7
Interest Expense	0.96	0.95	0.94	0.94	0.87	0.9	0.95	0.95	0.91	-0.9		0.69	0.52	0.68	0.93	0.9	0.84	0.48	-0.36	0.39	0.94	-0.14	-0.94	0.85	-0.76	-0.85
Income Before Tax	0.61	0.71	0.71	0.68	0.91	0.75	0.71	0.7	0.61	-0.57	0.69		0.94	0.93	0.7	0.54	0.43	0.85	-0.28	0.75	0.52	-0.57	-0.54	0.4	-0.74	-0.35
Net Income	0.49	0.61	0.62	0.58	0.76	0.62	0.58	0.61	0.53	-0.4	0.52	0.94		0.8	0.6	0.46	0.29	0.88	-0.12	0.67	0.32	-0.54	-0.3	0.28	-0.49	-0.17
Income Tax Expense	0.59	0.7	0.69	0.67	0.87	0.74	0.7	0.7	0.6	-0.58	0.68	0.93	0.8		0.71	0.52	0.41	0.68	-0.35	0.73	0.52	-0.56	-0.54	0.39	-0.74	-0.32
Research Development	0.94	0.99	0.98	0.99	0.81	0.89	0.94	0.99	0.96	-0.85	0.93	0.7	0.6	0.71		0.91	0.81	0.48	-0.28	0.33	0.84	-0.09	-0.81	0.8	-0.6	-0.75
Selling General Administrative	0.98	0.95	0.96	0.96	0.69	0.81	0.91	0.94	0.99	-0.78	0.9	0.54	0.46	0.52	0.91		0.8	0.41	-0.32	0.24	0.91	-0.13	-0.81	0.91	-0.5	-0.84
Selling And Marketing Expenses	0.84	0.81	0.81	0.81	0.61	0.73	0.79	0.81	0.8	-0.83	0.84	0.43	0.29	0.41	0.81	0.8		0.43	-0.21	0.33	0.82	0.13	-0.84	0.87	-0.4	-0.83
Net Income From Continuing Ops	0.44	0.52	0.53	0.48	0.69	0.57	0.53	0.51	0.43	-0.39	0.48	0.85	0.88	0.68	0.48	0.41	0.43		-0.16	0.85	0.32	-0.54	-0.34	0.35	-0.39	-0.19
Minority Interest	-0.4	-0.3	-0.32	-0.29	-0.35	-0.54	-0.5	-0.28	-0.29	0.15	-0.36	-0.28	-0.12	-0.35	-0.28	-0.32	-0.21	-0.16		-0.38	-0.54	0.23	0.52	-0.52	0.43	0.38
Tax Provision	0.3	0.36	0.36	0.32	0.61	0.52	0.44	0.35	0.27	-0.3	0.39	0.75	0.67	0.73	0.33	0.24	0.33	0.85	-0.38		0.28	-0.63	-0.34	0.27	-0.46	-0.08
Non Recurring	0.96	0.88	0.88	0.88	0.74	0.84	0.91	0.87	0.89	-0.79	0.94	0.52	0.32	0.52	0.84	0.91	0.82	0.32	-0.54	0.28		-0.11	-0.97	0.94	-0.68	-0.94
Interest Income	-0.12	-0.13	-0.13	-0.13	-0.46	-0.11	-0.12	-0.12	-0.14	-0.01	-0.14	-0.57	-0.54	-0.56	-0.09	-0.13	0.13	-0.54	0.23	-0.63	-0.11		0.04	-0.02	0.4	-0.06
Net Interest Income	-0.9	-0.83	-0.83	-0.82	-0.77	-0.85	-0.89	-0.82	-0.8	0.8	-0.94	-0.54	-0.3	-0.54	-0.81	-0.81	-0.84	-0.34	0.52	-0.34	-0.97	0.04		-0.88	0.75	0.91
Reconciled Depreciation	0.93	0.84	0.85	0.85	0.6	0.79	0.87	0.83	0.88	-0.7	0.85	0.4	0.28	0.39	0.8	0.91	0.87	0.35	-0.52	0.27	0.94	-0.02	-0.88		-0.43	-0.9
Extraordinary Items	-0.62	-0.6	-0.6	-0.58	-0.85	-0.69	-0.68	-0.6	-0.52	0.63	-0.76	-0.74	-0.49	-0.74	-0.6	-0.5	-0.4	-0.39	0.43	-0.46	-0.68	0.4	0.75	-0.43		0.55
Non Operating Income Net Other	-0.87	-0.77	-0.78	-0.79	-0.61	-0.68	-0.78	-0.77	-0.81	0.7	-0.85	-0.35	-0.17	-0.32	-0.75	-0.84	-0.83	-0.19	0.38	-0.08	-0.94	-0.06	0.91	-0.9	0.55

Click cells to compare fundamentals

STERIS Plc Account Relationship Matchups

STERIS Plc income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	197.2M	219.2M	553.1M	552.9M	565.2M	593.5M
Total Revenue	3.0B	3.1B	4.6B	5.0B	5.1B	5.4B
Gross Profit	1.3B	1.3B	2.0B	2.2B	2.2B	2.3B
Other Operating Expenses	2.5B	2.6B	4.2B	4.2B	4.3B	4.5B
Operating Income	341.1M	323.3M	425.6M	268.2M	836.1M	877.9M
Ebit	341.1M	581.1M	404.1M	791.1M	847.2M	889.5M
Ebitda	538.3M	800.3M	957.2M	1.3B	1.4B	1.5B
Cost Of Revenue	1.7B	1.8B	2.6B	2.8B	2.9B	3.1B
Total Operating Expenses	782.3M	797.6M	1.6B	1.4B	1.4B	1.5B
Total Other Income Expense Net	(39.0M)	(30.8M)	(58.8M)	(110.8M)	(133.3M)	(126.6M)
Interest Expense	40.3M	37.2M	89.6M	109.6M	144.4M	151.6M
Income Before Tax	498.7M	517.5M	314.5M	157.3M	702.8M	738.0M
Net Income	407.7M	397.4M	243.9M	107.0M	378.2M	397.2M
Income Tax Expense	90.9M	120.7M	71.6M	51.5M	149.5M	157.0M
Research Development	65.5M	66.3M	87.9M	101.6M	103.7M	108.9M
Selling General Administrative	704.1M	724.5M	1.5B	1.3B	1.2B	1.3B
Net Income Applicable To Common Shares	407.6M	397.4M	243.9M	107.0M	123.1M	154.1M
Selling And Marketing Expenses	12.7M	6.8M	15.6M	21.7M	25.5M	14.0M
Net Income From Continuing Ops	407.8M	396.9M	242.9M	105.8M	553.3M	279.0M
Minority Interest	12.8M	(530K)	1.0M	1.2M	(1.8M)	(1.7M)
Tax Provision	90.9M	120.7M	71.6M	51.5M	149.5M	92.3M
Non Recurring	31.0M	673K	(2.9M)	491.1M	564.7M	592.9M
Interest Income	38.3M	6.3M	6.3M	110.8M	11.0M	10.5M
Net Interest Income	(38.3M)	(30.8M)	(83.3M)	(110.8M)	(133.3M)	(126.6M)
Reconciled Depreciation	197.2M	219.2M	553.1M	552.9M	565.2M	391.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether STERIS plc is a strong investment it is important to analyze STERIS Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact STERIS Plc's future performance. For an informed investment choice regarding STERIS Stock, refer to the following important reports:

How To Invest In STERIS

Details

Is STERIS Stock a good investment?

Details

What is STERIS Plc's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.305

Dividend Share

2.13

Earnings Share

5.96

Revenue Per Share

53.903

Quarterly Revenue Growth

0.073

The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

STERIS Historical Income Statement

About STERIS Income Statement Analysis

STERIS Plc Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Net Interest Income

STERIS Plc income statement Correlations

STERIS Plc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

STERIS Plc income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Cost Of Revenue	+ 1.0	Gross Profit
Cost Of Revenue	+ 1.0	Other Operating Expenses

Net Interest Income	- 0.97	Non Recurring
Non Operating Income Net Other	- 0.94	Non Recurring
Net Interest Income	- 0.94	Interest Expense
Non Operating Income Net Other	- 0.9	Reconciled Depreciation
Interest Expense	- 0.9	Total Other Income Expense Net
Net Interest Income	- 0.9	Depreciation And Amortization